OGN vs OPK · P/E 3.4, rev $3.02B vs rev $287.8M
Organon & Co (OGN) versus Opko Health Inc (OPK) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Opko Health Inc (OPK) is a diagnostics & research company listed on US.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported OPK revenue for 2026-06-30 was $287.8M. Net income was -$63.3M. OPK currently screens at market cap $1.07B.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. OPK currently screens at market cap $1.07B.
Not investment advice. Open the OGN and OPK stock pages for the full models.
Not investment advice.